- Location
Dako
"-
Digital Pathology Solution for Breast Cancer Diagnostics Is Introduced by Dako and Omnyx
Sep 3, 2013Dako, a Danish provider of tissue-based cancer diagnostics, and Omnyx, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, have launched clinical image analysis for digital pathology in Europe. As part of the ...
Tags: Health, Medicine, digital pathology
-
Clone EP1 Antibody for Breast Cancer Treatment Will Be Sold by Dako Getting FDA Consent
Apr 8, 2013Agilent Technologies' company, Dako, has announced that US Food and Drug Administration (FDA) has given consent to sell its Clone EP1 diagnostic tool for breast cancer treatment in the US market. The antibody, called FLEX Monoclonal ...
-
Dako has launched instant quality in situ hybridization technology
Feb 19, 2013Dako, an Agilent Technologies Company, has launched instant quality in situ hybridization (IQISH) technology in the US, to lessen cancer evaluation turnaround time. IQISH technology, based on Dako's fast IQISH hybridization buffer ...
Tags: IQISH technology, cancer evaluation, cancer treatments
-
Dako Has Entered Into Collaboration Agreement with Pfizer
Feb 19, 2013Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...
Tags: cancer diagnostics solutions, Dako, Pfizer
-
Dako Received Approval From The US Food and Drug Administration
Dec 5, 2012Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...
Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit
-
FDA Approval Herceptest and Her2 Fish Fish Diagnostic Tools Has Been Received by Dako
Jun 12, 2012Dako, a Danish provider of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and HER2 FISH pharmDx Kit as companion diagnostics for pertuzumab (Perjeta) - a new Genentech ...
Tags: Dako, cancer diagnostics solutions, HercepTest, HER2 FISH
